Clinical Trials

Showing trials with last updates posted in 2026.

NCT05978167 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
20 participants

Targeting Drug Memories With Methylphenidate

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2023-06-23
Completion:
2031-03-31
Conditions
  • Substance Use Disorder
  • Cocaine Use Disorder
Interventions
  • DRUG
  • BEHAVIORAL
No Results Yet
NCT05967468 | ACTIVE_NOT_RECRUITING | NA
100 participants

Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2023-09-14
Completion:
2025-12-30
Conditions
  • Obsessive-Compulsive Disorder in Children
  • Anxiety Disorder of Childhood
  • Social Anxiety Disorder of Childhood
  • Obsessive-Compulsive Disorder in Adolescence
  • Generalized Anxiety Disorder
  • Separation Anxiety
  • Panic Disorder
  • Panic Disorder With Agoraphobia
  • Panic Attacks
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT05918640 | RECRUITING | PHASE1/PHASE2
63 participants

Lurbinectedin in FET-Fused Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2023-07-27
Completion:
2028-07-30
Conditions
  • Ewing Sarcoma
  • Desmoplastic Small Round Cell Tumor
  • Pediatric Cancer
  • Undifferentiated Sarcoma
Interventions
  • DRUG
No Results Yet
NCT05868226 | RECRUITING | PHASE1/PHASE2
280 participants

PRE-ISPY Phase I/II Oncology Platform Program

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2023-02-15
Completion:
2030-12-30
Conditions
  • HER2-positive Breast Cancer
  • Metastatic Cancer
  • Metastatic Breast Cancer
  • Metastatic
  • HER2-positive Metastatic Breast Cancer
  • HER2 Mutation-Related Tumors
  • HER-2 Protein Overexpression
  • HER2-negative Breast Cancer
  • Triple Negative Breast Cancer
  • HR Positive
  • Hormone Receptor-positive Breast Cancer
  • Estrogen Receptor Positive Tumor
  • Progesterone Receptor-positive Breast Cancer
  • Hormone Receptor Negative Breast Carcinoma
  • Solid Tumor
  • Solid Tumor, Adult
  • Solid Carcinoma
  • HER2 Low Breast Cancer
  • HER2 Low Breast Carcinoma
  • ER Positive Breast Cancer
  • PR-positive Breast Cancer
  • Minimal Residual Disease
  • Colo-rectal Cancer
  • Colon Cancer
  • Rectal Cancer
  • ctDNA Monitoring
  • Colorectal Neoplasms
  • Colonic Neoplasms
  • Rectal Neoplasms
  • Neoplasm, Residual
  • Adenocarcinoma of Colon
  • Adenocarcinoma
Interventions
  • DRUG
No Results Yet
NCT05864144 | COMPLETED | PHASE1/PHASE2
98 participants

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2023-05-31
Completion:
2026-06-02
Conditions
  • Solid Tumor, Adult
  • Advanced Solid Tumor
  • Head and Neck Cancer
  • Breast Cancer
  • Colon Cancer
  • Pancreatic Cancer
  • Gastric Cancer
  • Esophageal Cancer
  • Prostate Cancer
  • Uterine Cancer
  • Cervix Cancer
  • Ovarian Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Thyroid Cancer
  • Melanoma
  • Sarcoma
  • Advanced Cancer
  • Metastatic Cancer
  • Refractory Cancer
  • Non Small Cell Lung Cancer
  • Merkel Cell Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page